Hadassah's Innovative Treatment for Multiple Sclerosis: Transplanting Stem Cells from Patient's Bone Marrow

Yes, this article is from November 2007, but with so many always asking me for details, I thought I would provide it for those who want to be empowered. Hadassah's Innovative Treatment for Multiple Sclerosis: TransplantingStem Cells from Pa...

Yes, this article is from November 2007, but with so many always asking me for details, I thought I would provide it for those who want to be empowered.

Hadassah's Innovative Treatment for Multiple Sclerosis: Transplanting
Stem Cells from Patient's Bone Marrow

New Multiple Sclerosis Center Launched at Hadassah

22/11/07


A treatment developed at Hadassah, still in the research stage, has been tested on 25 multiple sclerosis and ALS (Lou Gehrig's Disease) patients. Professor Dmitrius Karussis, a senior neurologist at Hadassah and the director of the new Multiple Sclerosis Center, working in collaboration with the University of Athens, and Professor Shimon Slavin, the former director of the Department of Bone Marrow Transplantation (BMT) and the BMT Laboratory at Hadassah, discovered that it is possible to remove stem cells from a patient's bone marrow, to isolate these cells under special conditions and to generate over 50 million cells within two months. As part of this process, mesenchymal cells (mature stem cells) are extracted from the patient and transplanted by a lumbar injection in the spinal column (into the spinal fluid of the central nervous system), with each patient serving as his/her own donor. The transplanted cells are marked in order to track and verify that they reach the intended destination in the patient's body.

%26raquo; Read More